Dergiler / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 1

Nifedipine and indomethacin in preventing preterm labor under 32 gestational weeks

Sayfa
79–83
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, delivery after gestational 34 weeks and 37 weeks were significantly higher in the nifedipine group (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: This study compared nifedipine and indomethacin treatments, commonly used tocolytic agents, in terms of efficacy and maternal side effects.
📊
Temel Bulgular & Veri:Methods: This retrospective study included pregnant women spontaneous preterm labor between 24 and 32 weeks of gestation who were treated with indomethacin or nifedipine between January 2017 and June 2020.
💡
Sonuç & Katkı:However, delivery after gestational 34 weeks and 37 weeks were significantly higher in the nifedipine group (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aims: This study compared nifedipine and indomethacin treatments, commonly used tocolytic agents, in terms of efficacy and maternal side effects. Methods: This retrospective study included pregnant women spontaneous preterm labor between 24 and 32 weeks of gestation who were treated with indomethacin or nifedipine between January 2017 and June 2020. Subjects with polyhydramnios, multiple pregnancies, preterm premature rupture of membranes, and those with 4 cm or more cervical dilatation, and who required emergency cesarean delivery were excluded. Study endpoints were delivery within 48 h, prolongation of pregnancy up to 34 weeks and 37 weeks, and maternal side effects. Results: A total of 307 pregnant women were analyzed. Nifedipine and indomethacin were administered to 205 and 102 patients, respectively. The median maternal age was 25 years in both groups. The rate of delivery within 48 h was significantly higher by 20.6% among subjects who received indomethacin compared with the 9.8% delivery rate among subjects who received nifedipine (p=0.009). However, delivery after gestational 34 weeks and 37 weeks were significantly higher in the nifedipine group (p

🔖

Bu Makaleye Atıf Yap

ÇELEN, Ş., ÇAĞLAR, A. T., ÇELİK, Ö. Y., KELEŞ, A., DAĞDEVİREN, G., AKSOY, M. (2022). Nifedipine and indomethacin in preventing preterm labor under 32 gestational weeks. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 1, 79–83. https://ajindex.com/articles/526759

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 171: Management of Preterm Labor. Obstet Gynecol. 2016;128:155-164
  2. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;37:2162- 2172
  3. World Health Organization WHO, March of Dimes, Partnership for Maternal, Newborn & Child Health, Save the Children. Born too soon: the global action report on preterm birth. Last Accessed Date: February 15, 2021. Available from: www.who. int/maternal _ child _adolescent/documents/born_too_soon/ en/ 4. Robinson JN, Norwitz ER. Preterm birth: risk factors, interventions for risk reduction, and maternal prognosis. Uptodate. https://www.uptodate.com/contents/preterm-birthrisk-factors-interventions-for-risk-reduction -and-maternalprognosis. Accessed March 1, 2021 5. Lewit EM, Baker LS, Corman H, Shiono PH. The direct cost of low birth weight. Future Child. 1995;5:35-56
  4. Ferguson JE, Dyson DC, Holbrook RH Jr, Schutz T, Stevenson DK. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol. 1989;161:788-795
  5. Ferguson JE, Dyson DC, Schutz T, Stevenson DK. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol. 1990;163:105-111
  6. Bracero LA, Leikin E, Kirshenbaum N, Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol. 1991;8:365-369
  7. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226
  8. Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. Br J Obstet Gynecol. 2003;110:1045-1049
  9. Hanley M, Sayres L, Reiff ES, Wood A, Grotegut CA, Kuller JA. Tocolysis: A Review of the Literature. Obstet Gynecol Surv. 2019;74:50-55
  10. Simhan HN, Caritis S. Inhibition of acute preterm labor. UpToDate. [cited 2021 March 1] Available from: https://www. uptodate.com/contents/inhibition-of-acute-preterm-labor 13. Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifed